Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04731077 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Avenir Complete Post-Market Clinical Follow-Up Study

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Recruiting to Active, Not Recruiting Enrollment target: estimated 300 to confirmed 275 · Site details revised at 9 of 9 sitesv8 Show 2 more changesShow less
    • Enrollment target: estimated 300 to confirmed 275
    • Site details revised at 9 of 9 sites
  2. Primary completion date: Jun 1, 2033 to Jun 1, 2035 Study sites: 3 to 9 · Completion date: Jun 1, 2034 to Jun 1, 2036v7 Show 2 more changesShow less
    • Study sites: 3 to 9
    • Completion date: Jun 1, 2034 to Jun 1, 2036
  3. Study sites: 1 to 3v6
  4. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date changed from estimate of Dec 1, 2021 to Sep 27, 2021v5 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Dec 1, 2021 to Sep 27, 2021
  5. Start date: Oct 1, 2021 to Dec 1, 2021v4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Aug 1, 2021 to Oct 1, 2021v3
  2. Start date: Jun 1, 2021 to Aug 1, 2021 Secondary endpoints: details revised at 3 of 5 entriesv2 Show 1 more changeShow less
    • Secondary endpoints: details revised at 3 of 5 entries
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Zimmer Biomet
83 trials monitored
See 1 trial at risk
The main objectives of this study are to confirm the long-term safety, performance and clinical benefits the Avenir Complete femoral stem and its instrumentation when used in primary total, hemi, and revision hip arthroplasty.
Trial Details
NCT Number NCT04731077
Lead Sponsor Zimmer Biomet
Conditions Osteoarthritis, Hip, Avascular Necrosis of Hip, Avascular Necrosis of the Femoral Head, Post-traumatic; Arthrosis
Enrollment 275 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov